Safety Alerts & Recalls
What does this mean?
This recall for Motrin IB was issued at a warehouse and retail level only. The FDA and the manufacturer have determined that any recalled product that may have been dispensed to patients does not pose a significant health risk. If you take Motrin IB 200 mg and are concerned about this recall, you should follow up with your doctor or pharmacist.
McNeil Healthcare Recalls Additional Lot of Motrin IB
McNeil Healthcare, LLC has recalled another lot of Motrin: Motrin IB (Ibuprofen) Caplets, 200mg, Pain Reliever/Fever Reduce, available over-the-counter (OTC) in bottles of 24 Coated Caplets. Lot number SDA149 has been recalled because this lot failed the manufacturer routine tests that measure the capsules' ability to dissolve.
This recall for lot number SDA149 of Motrin IB Caplets, 200 mg in bottles of 24 caplets is in addition to the previous McNeil recalls alerts for Motrin IB products.
To view the FDA notice about this recall, please visit: more information here